{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:33:45Z","timestamp":1778078025000,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T00:00:00Z","timestamp":1455753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos.81070154"],"award-info":[{"award-number":["Nos.81070154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos.81270258"],"award-info":[{"award-number":["Nos.81270258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Committee of Science and Technology","award":["Nos. 11JC1408200"],"award-info":[{"award-number":["Nos. 11JC1408200"]}]},{"name":"Shanghai Committee of Science and Technology","award":["Nos. 12411951900"],"award-info":[{"award-number":["Nos. 12411951900"]}]},{"name":"Shanghai Committee of Science and Technology","award":["Nos.13140903801"],"award-info":[{"award-number":["Nos.13140903801"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00395-016-0536-7","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T14:52:05Z","timestamp":1455807125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK\/-JNK1\/2 signaling pathway"],"prefix":"10.1007","volume":"111","author":[{"given":"Chang-Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Chao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-He","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Wen","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,18]]},"reference":[{"key":"536_CR1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","volume":"99","author":"CL Antos","year":"2002","unstructured":"Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM, Richardson JA, Hill JA, Olson EN (2002) Activated glycogen synthase-3\u03b2 suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci 99:907\u2013912. doi: 10.1073\/pnas.231619298","journal-title":"Proc Natl Acad Sci"},{"key":"536_CR2","author":"N Biesemann","year":"2015","unstructured":"Biesemann N, Mendler L, Kostin S, Wietelmann A, Borchardt T, Braun T (2015) Myostatin induces interstitial fibrosis in the heart via TAK1 and p38. Cell Tissue Res. doi: 10.1007\/s00441-015-2139-2","journal-title":"Cell Tissue Res"},{"key":"536_CR3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCULATIONAHA.114.010686","volume":"131","author":"M Bisserier","year":"2015","unstructured":"Bisserier M, Berthouze-Duquesnes M, Breckler M, Tortosa F, Fazal L, de Regibus A, Laurent AC, Varin A, Lucas A, Branchereau M, Marck P, Schickel JN, Delomenie C, Cazorla O, Soulas-Sprauel P, Crozatier B, Morel E, Heymes C, Lezoualc\u2019h F (2015) Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+\/calmodulin-dependent protein kinase II signaling. Circulation 131:390\u2013400. doi: 10.1161\/CIRCULATIONAHA.114.010686 (discussion 400)","journal-title":"Circulation"},{"key":"536_CR4","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI200317295","volume":"111","author":"JC Braz","year":"2003","unstructured":"Braz JC, Bueno OF, Liang Q, Wilkins BJ, Dai YS, Parsons S, Braunwart J, Glascock BJ, Klevitsky R, Kimball TF, Hewett TE, Molkentin JD (2003) Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J Clin Invest 111:1475\u20131486. doi: 10.1172\/JCI17295","journal-title":"J Clin Invest"},{"key":"536_CR5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30\u201341. doi: 10.1038\/nrcardio.2010.165","journal-title":"Nat Rev Cardiol"},{"key":"536_CR6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/eurheartj\/ehm605","volume":"29","author":"G Simone de","year":"2008","unstructured":"de Simone G, Gottdiener JS, Chinali M, Maurer MS (2008) Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 29:741\u2013747. doi: 10.1093\/eurheartj\/ehm605","journal-title":"Eur Heart J"},{"key":"536_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","volume":"123","author":"MH Drazner","year":"2011","unstructured":"Drazner MH (2011) The progression of hypertensive heart disease. Circulation 123:327\u2013334. doi: 10.1161\/CIRCULATIONAHA.108.845792","journal-title":"Circulation"},{"key":"536_CR8","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2003.11.064","volume":"43","author":"MH Drazner","year":"2004","unstructured":"Drazner MH, Rame JE, Marino EK, Gottdiener JS, Kitzman DW, Gardin JM, Manolio TA, Dries DL, Siscovick DS (2004) Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol 43:2207\u20132215. doi: 10.1016\/j.jacc.2003.11.064","journal-title":"J Am Coll Cardiol"},{"key":"536_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0955-0674(99)80028-3","volume":"11","author":"TP Garrington","year":"1999","unstructured":"Garrington TP, Johnson GL (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr Opin Cell Biol 11:211\u2013218. doi: 10.1016\/S0955-0674(99)80028-3","journal-title":"Curr Opin Cell Biol"},{"key":"536_CR10","doi-asserted-by":"crossref","unstructured":"Greenberg B (2015) CUPID 2: a phase 2b trial investigating the efficacy and safety of the intracoronary administration of AAV1\/SERCA2a in patients with advanced heart failure. 917\u2014Hot Line V\u2014Heart Failure, London","DOI":"10.1016\/j.cardfail.2015.09.012"},{"key":"536_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1172\/JCI62837","volume":"123","author":"RJ Hajjar","year":"2013","unstructured":"Hajjar RJ (2013) Potential of gene therapy as a treatment for heart failure. J Clin Invest 123:53\u201361. doi: 10.1172\/JCI62837","journal-title":"J Clin Invest"},{"key":"536_CR12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrm1983","volume":"7","author":"J Heineke","year":"2006","unstructured":"Heineke J, Molkentin JD (2006) Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7:589\u2013600. doi: 10.1038\/nrm1983","journal-title":"Nat Rev Mol Cell Biol"},{"key":"536_CR13","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","volume":"358","author":"JA Hill","year":"2008","unstructured":"Hill JA, Olson EN (2008) Cardiac plasticity. N Engl J Med 358:1370\u20131380. doi: 10.1056\/NEJMra072139","journal-title":"N Engl J Med"},{"key":"536_CR14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd2289","volume":"6","author":"KL Jeffrey","year":"2007","unstructured":"Jeffrey KL, Camps M, Rommel C, Mackay CR (2007) Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov 6:391\u2013403. doi: 10.1038\/nrd2289","journal-title":"Nat Rev Drug Discov"},{"key":"536_CR15","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1038\/ncomms4303","volume":"5","author":"DS Jiang","year":"2014","unstructured":"Jiang DS, Wei X, Zhang XF, Liu Y, Zhang Y, Chen K, Gao L, Zhou H, Zhu XH, Liu PP, Bond Lau W, Ma X, Zou Y, Zhang XD, Fan GC, Li H (2014) IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling. Nat Commun 5:3303. doi: 10.1038\/ncomms4303","journal-title":"Nat Commun"},{"key":"536_CR16","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1210\/me.2004-0503","volume":"19","author":"K Kinugawa","year":"2005","unstructured":"Kinugawa K, Jeong MY, Bristow MR, Long CS (2005) Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor \u03b11-specific manner that requires TAK1 and p38 mitogen-activated protein kinase. Mol Endocrinol 19:1618\u20131628. doi: 10.1210\/me.2004-0503","journal-title":"Mol Endocrinol"},{"key":"536_CR17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2337\/db07-1414","volume":"57","author":"S Klinger","year":"2008","unstructured":"Klinger S, Poussin C, Debril MB, Dolci W, Halban PA, Thorens B (2008) Increasing GLP-1-induced \u03b2-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-\u03b1 and DUSP14. Diabetes 57:584\u2013593. doi: 10.2337\/db07-1414","journal-title":"Diabetes"},{"key":"536_CR18","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1172\/JCI44824","volume":"121","author":"N Koitabashi","year":"2011","unstructured":"Koitabashi N, Danner T, Zaiman AL, Pinto YM, Rowell J, Mankowski J, Zhang D, Nakamura T, Takimoto E, Kass DA (2011) Pivotal role of cardiomyocyte TGF-\u03b2 signaling in the murine pathological response to sustained pressure overload. J Clin Invest 121:2301\u20132312. doi: 10.1172\/JCI44824","journal-title":"J Clin Invest"},{"key":"536_CR19","doi-asserted-by":"crossref","first-page":"13818","DOI":"10.1073\/pnas.1008397107","volume":"107","author":"H Li","year":"2010","unstructured":"Li H, He C, Feng J, Zhang Y, Tang Q, Bian Z, Bai X, Zhou H, Jiang H, Heximer SP, Qin M, Huang H, Liu PP, Huang C (2010) Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc Natl Acad Sci 107:13818\u201313823. doi: 10.1073\/pnas.1008397107","journal-title":"Proc Natl Acad Sci"},{"key":"536_CR20","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/emboj\/cdg474","volume":"22","author":"Q Liang","year":"2003","unstructured":"Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD (2003) c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin\u2013NFAT signaling. EMBO J 22:5079\u20135089. doi: 10.1093\/emboj\/cdg474","journal-title":"EMBO J"},{"key":"536_CR21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","volume":"102","author":"BH Lorell","year":"2000","unstructured":"Lorell BH, Carabello BA (2000) Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 102:470\u2013479","journal-title":"Circulation"},{"key":"536_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2008.08.050","volume":"1239","author":"C Marie-Claire","year":"2008","unstructured":"Marie-Claire C, Benturquia N, Lundqvist A, Courtin C, Noble F (2008) Characteristics of dual specificity phosphatases mRNA regulation by 3,4-methylenedioxymethamphetamine acute treatment in mice striatum. Brain Res 1239:42\u201348. doi: 10.1016\/j.brainres.2008.08.050","journal-title":"Brain Res"},{"key":"536_CR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4049\/jimmunol.166.1.197","volume":"166","author":"F Marti","year":"2001","unstructured":"Marti F, Krause A, Post NH, Lyddane C, Dupont B, Sadelain M, King PD (2001) Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6. J Immunol 166:197\u2013206","journal-title":"J Immunol"},{"key":"536_CR24","doi-asserted-by":"crossref","first-page":"H709","DOI":"10.1152\/ajpheart.00186.2005","volume":"290","author":"M Matsumoto-Ida","year":"2006","unstructured":"Matsumoto-Ida M, Takimoto Y, Aoyama T, Akao M, Takeda T, Kita T (2006) Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 290:H709\u2013H715. doi: 10.1152\/ajpheart.00186.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"536_CR25","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1073\/pnas.062453699","volume":"99","author":"T Minamino","year":"2002","unstructured":"Minamino T, Yujiri T, Terada N, Taffet GE, Michael LH, Johnson GL, Schneider MD (2002) MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq. Proc Natl Acad Sci 99:3866\u20133871. doi: 10.1073\/pnas.062453699","journal-title":"Proc Natl Acad Sci"},{"key":"536_CR26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/BJ20082234","volume":"418","author":"KI Patterson","year":"2009","unstructured":"Patterson KI, Brummer T, O\u2019Brien PM, Daly RJ (2009) Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 418:475\u2013489","journal-title":"Biochem J"},{"key":"536_CR27","author":"W Qin","year":"2014","unstructured":"Qin W, Du N, Zhang L, Wu X, Hu Y, Li X, Shen N, Li Y, Yang B, Xu C, Fang Z, Lu Y, Zhang Y, Du Z (2014) Genistein alleviates pressure overload-induced cardiac dysfunction and interstitial fibrosis in mice. Br J Pharmacol. doi: 10.1111\/bph.13002","journal-title":"Br J Pharmacol"},{"key":"536_CR28","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","volume":"88","author":"HA Rockman","year":"1991","unstructured":"Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR (1991) Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci 88:8277\u20138281","journal-title":"Proc Natl Acad Sci"},{"key":"536_CR29","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","volume":"90","author":"BA Rose","year":"2010","unstructured":"Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90:1507\u20131546. doi: 10.1152\/physrev.00054.2009","journal-title":"Physiol Rev"},{"key":"536_CR30","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1161\/CIRCULATIONAHA.106.657981","volume":"115","author":"M Satoh","year":"2007","unstructured":"Satoh M, Matter CM, Ogita H, Takeshita K, Wang CY, Dorn GW 2nd, Liao JK (2007) Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 115:3197\u20133204. doi: 10.1161\/CIRCULATIONAHA.106.657981","journal-title":"Circulation"},{"key":"536_CR31","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1101\/gad.1360605","volume":"19","author":"JH Shim","year":"2005","unstructured":"Shim JH, Xiao C, Paschal AE, Bailey ST, Rao P, Hayden MS, Lee KY, Bussey C, Steckel M, Tanaka N, Yamada G, Akira S, Matsumoto K, Ghosh S (2005) TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev 19:2668\u20132681. doi: 10.1101\/gad.1360605","journal-title":"Genes Dev"},{"key":"536_CR32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cell.2011.12.033","volume":"148","author":"A Singh","year":"2012","unstructured":"Singh A, Sweeney MF, Yu M, Burger A, Greninger P, Benes C, Haber DA, Settleman J (2012) TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers. Cell 148:639\u2013650. doi: 10.1016\/j.cell.2011.12.033","journal-title":"Cell"},{"key":"536_CR33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0735-1097(00)01123-2","volume":"37","author":"K Tanaka","year":"2001","unstructured":"Tanaka K, Honda M, Takabatake T (2001) Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol 37:676\u2013685. doi: 10.1016\/S0735-1097(00)01123-2","journal-title":"J Am Coll Cardiol"},{"key":"536_CR34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbadis.2012.11.007","volume":"1832","author":"AV Villar","year":"2013","unstructured":"Villar AV, Garcia R, Llano M, Cobo M, Merino D, Lantero A, Tramullas M, Hurle JM, Hurle MA, Nistal JF (2013) BAMBI (BMP and activin membrane-bound inhibitor) protects the murine heart from pressure-overload biomechanical stress by restraining TGF-\u03b2 signaling. Biochim Biophys Acta 1832:323\u2013335. doi: 10.1016\/j.bbadis.2012.11.007","journal-title":"Biochim Biophys Acta"},{"key":"536_CR35","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1074\/jbc.271.16.9535","volume":"271","author":"KC Wollert","year":"1996","unstructured":"Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR (1996) Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130\/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 271:9535\u20139545","journal-title":"J Biol Chem"},{"key":"536_CR36","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1126\/science.270.5244.2008","volume":"270","author":"K Yamaguchi","year":"1995","unstructured":"Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-\u03b2 signal transduction. Science 270:2008\u20132011","journal-title":"Science"},{"key":"536_CR37","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.4049\/jimmunol.1300989","volume":"192","author":"CY Yang","year":"2014","unstructured":"Yang CY, Li JP, Chiu LL, Lan JL, Chen DY, Chuang HC, Huang CY, Tan TH (2014) Dual-specificity phosphatase 14 (DUSP14\/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation. J Immunol 192:1547\u20131557. doi: 10.4049\/jimmunol.1300989","journal-title":"J Immunol"},{"key":"536_CR38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/75037","volume":"6","author":"D Zhang","year":"2000","unstructured":"Zhang D, Gaussin V, Taffet GE, Belaguli NS, Yamada M, Schwartz RJ, Michael LH, Overbeek PA, Schneider MD (2000) TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 6:556\u2013563. doi: 10.1038\/75037","journal-title":"Nat Med"},{"key":"536_CR39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1074\/jbc.M112.412643","volume":"288","author":"H Zheng","year":"2013","unstructured":"Zheng H, Li Q, Chen R, Zhang J, Ran Y, He X, Li S, Shu HB (2013) The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-\u03baB activation by dephosphorylating the protein kinase TAK1. J Biol Chem 288:819\u2013825. doi: 10.1074\/jbc.M112.412643","journal-title":"J Biol Chem"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-016-0536-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00395-016-0536-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-016-0536-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T14:45:50Z","timestamp":1567608350000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00395-016-0536-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,18]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s00395-016-0536-7","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,18]]},"article-number":"19"}}